Ann: FDA Clears iTrack Advance for US Launch, page-46

Hopefully not, I'd rather see Nova Eye reach its full potential rather than be acquired so early in its journey.

Nonetheless, there has been lots of M&A in the MIGS space recently, with one last year for a pre-revenue MIGS manufacturer that won't receive FDA approval for years fetching a price tag 15x higher than the current market cap of EYE (which is already revenue generating, and as of a few weeks ago FDA approved). Nova Eye certainly looks very cheap relative to recent comps (and therefore very appealing to big pharma/PE)